Advanced search
Publication Cover
Journal of Medical Economics Volume 15, 2012 - Issue 3
Submit an article Journal homepage
689
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder

Bram G. VerheggenPharmerit International Rotterdamthe NetherlandsCorrespondence[email protected]
,
Richard LeeCornell University New York, NYUSA
,
Michelle M. Lieuw OnPharmerit Europe Rotterdamthe Netherlands
,
Maarten J. TreurPharmerit Europe Rotterdamthe Netherlands
,
Marc F. BottemanPharmerit International Bethesda, MDUSA
,
Steven A. KaplanCornell University New York, NYUSA
&
Jeffrey N. TrocioPfizer Inc New York, NYUSA
 show all
Pages 586-600 | Accepted 10 Feb 2012, Published online: 24 Feb 2012

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Konstantinos Giannitsas & Anastasios Athanasopoulos. (2015) A review of cost–effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 413-423.
Read now

Articles from other publishers (6)

Haitao Gong, Zhenshan Ding, Binbin Jiao, Jian Ren & Qingsong Yu. (2023) Advanced Sensoring Technologies for Evaluation and Management of Lower Urinary Tract Symptoms. Advanced Sensor Research.
Crossref
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Ana Mª. Mora & Marta Hernández. (2017) Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia. BMC Urology 17:1.
Crossref
Jameel Nazir, Lars Heemstra, Anke van Engen, Zalmai Hakimi & Cristina Ivanescu. (2015) Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. BMC Urology 15:1.
Crossref
Konstantinos Giannitsas & Anastasios Athanasopoulos. (2013) Male overactive bladder. Current Opinion in Urology 23:6, pages 515-519.
Crossref
Tomas L. Griebling. (2013) Overactive Bladder in Elderly Men: Epidemiology, Evaluation, Clinical Effects, and Management. Current Urology Reports 14:5, pages 418-425.
Crossref
Claudius Füllhase, Christopher Chapple, Jean-Nicolas Cornu, Cosimo De Nunzio, Christian Gratzke, Steven A. Kaplan, Michael Marberger, Francesco Montorsi, Giacomo Novara, Matthias Oelke, Hartmut Porst, Claus Roehrborn, Christian Stief & Kevin T. McVary. (2013) Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms. European Urology 64:2, pages 228-243.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.